Astrotech

Astrotech Corp. engages in the provision of science and technology development and commercialization businesses. It operates through the following segments: Astrotech Technologies Inc, 1st Detect Corporation, AgLAB Inc, and BreathTech Corporation. The company was founded in 1984 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Astrotech Corp. engages in the mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. Its business units include 1st Detect, BreathTech, and AgLab. The company was founded in 1984 and is headquartered in Austin, TX.

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022. The 2022 Annual Meeting will be held at 9:00 a.m. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the Company's main office. The Company anticipates sending proxy materials for the annual meeting to stockholders in September 2022. Astrotec

Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation announces that it has appointed Jim Becker to its Board of Directors.

Astrotech Appoints Jim Becker to Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation announces it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus.

Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.

Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)---- $ASTC #earnings--Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021. Astrotech had its best quarter since sales of 1st Detect's TRACER 1000™ began, with revenue related to the TRACER 1000 up 332% compared to the same period one year ago. After garnering initial traction in the cargo security market due to the TRACER 1000's near-zero false alarm rate, in the se

Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)---- $ASTC #COVID--Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants. Dr. Sirgi is a pathologist, board certified in Anatomic, Clinical and Cytopathology, and has over 30 years of practice and leadership experience in private and academic pathology practi

Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as Its Chief Science Officer

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2021 annual meeting of stockholders (the “2021 Annual Meeting”) on Friday, March 25, 2022. The 2021 Annual Meeting will be held at 9:00 A.M. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the AT&T Hotel and Conference Center. The Company anticipates sending proxy materials for the annual meeting to stockholders in February 2022

Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder Proposals

AUSTIN, Texas--(BUSINESS WIRE)-- #Astrotech--Astrotech Corporation (Nasdaq: ASTC) now intends to actively pursue strategic and accretive acquisition opportunities. Tom Wilkson, as Lead Independent Director, will focus on identifying strategic acquisitions for Astrotech Corporation and its subsidiaries. Mr. Wilkinson has been a board member of Astrotech since 2018. He has extensive experience in M&A, strategy, and leading public companies, most recently as Chief Executive Officer of Xplore Technologies,

Astrotech Begins Search for Strategic Acquisitions

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the first quarter of fiscal year 2022, which ended September 30, 2021. The first quarter of fiscal year 2022 saw a continued increase in commercial sales of 1st Detect's TRACER 1000™, the first and only mass spectrometry-based explosives trace detector (ETD) certified for air and cargo security. This quarter, 1st Detect achieved a significant milestone whereby we received our first purchase o

Astrotech Reports First Quarter of Fiscal Year 2022 Financial Results

Astrotech Corp (NASDAQ: ASTC) reported FY21 revenue of $0.334 million, a decrease of 31.6% year-over-year. Loss from operations reduced to $(7.91) million, compared to $(8.11) million a year ago.

Astrotech Stock Slips After FY21 Results

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the fiscal year ended June 30, 2021. Fiscal year 2021 represented a turning point for Astrotech Corporation. We successfully raised a total of $74.3 million in gross proceeds from equity offerings, strengthening our balance sheet and sufficiently capitalizing the company for the foreseeable future. We plan to ramp sales of our mass spectrometry instrumentation and explore other strategic oppo

Astrotech Reports Fiscal Year 2021 Financial Results

Astrotech Corp (NASDAQ: ASTC) subsidiary 1st Detect  has secured a purchase order for its TRACER 1000, representing the first units deployed at an airport security checkpoint. The financial terms of the order were not disclosed.

Astrotech Stock Surges On First Purchase Order For Checkpoint Security

The stock price of Astrotech Corporation (NASDAQ: ASTC) increased by over 15% pre-market. This is why it happened.

ASTC Stock: Over 15% Increase Pre-Market Explanation

AUSTIN, Texas--(BUSINESS WIRE)-- #airportsecurity--Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st Detect subsidiary has secured an important landmark purchase order for its TRACER 1000™, representing the first units to be deployed at an airport security checkpoint. Including prior sales to worldwide cargo facilities, the TRACER 1000 explosives trace detector (ETD) will now be operating in fifteen locations in ten countries throughout Europe and Asia. The Astrotech Mass Spectrometer Technology™

1st Detect Lands First Purchase Order for Checkpoint Security

AUSTIN, Texas--(BUSINESS WIRE)-- #Aglab--Astrotech Corporation (NASDAQ: ASTC) announced today that its AgLAB Inc. subsidiary has hired Joe Levinthal, a hemp and cannabis industry veteran and an expert in mass spectrometry, as its Chief Science Officer, to help lead AgLAB's product development team. Joe brings an extensive background in applying highly complex scientific instrumentation to develop products derived from hemp and cannabis, and he has worked with some of the leading companies in the industr

Astrotech Hires Industry Veteran Joe Levinthal to Lead AgLAB's Science Team

Chico's FAS

Looking for top penny stocks this week? Check these 3 out for your watchlist The post Best Penny Stocks to Buy This Week?

Best Penny Stocks to Buy This Week? Here's 3 To Watch

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the third quarter of fiscal year 2021, which ended March 31, 2021. During and subsequent to quarter end, we continued to strengthen our balance sheet for future growth by raising $50.1 million in total proceeds. As we expect to ramp up sales of our TRACER 1000™ explosives trace detector (ETD), launch the AgLAB-1000-D2™, and develop, in partnership with the Cleveland Clinic Foundation (Clevela

Astrotech Reports Third Quarter of Fiscal Year 2021 Financial Results

Ebang International Holdings

China Rapid Finance

Uxin Ltd - ADR

Why Penny Stocks Are Pushing Up Alongside Cryptocurrency The post Penny Stocks To Watch With Cryptocurrency in Focus appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Watch With Cryptocurrency in Focus

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), announced today the closing of its previously announced underwritten public offering of 24,885,828 shares of its common stock, which included 3,245,977 shares sold pursuant to the full exercise of the underwriter's option to purchase additional shares, at a price to the public of $1.50 per share, less underwriting discounts and commissions. The gross proceeds to the Company from the offering were approximately $37.3 million,

Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

The stock price of Astrotech Corp (NASDAQ: ASTC) fell by over 25% pre-market. This is why it happened.

Astrotech Stock Price Fell Over 25% Pre-Market: Why It Happened

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 21,639,851 shares of common stock of the Company at a price to the public of $1.50 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about April 12, 2021, subject to satisfaction of customary closing

Astrotech Increases Previously Announced Bought Deal Offering of Common Stock to $32.5 Million

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,666,667 shares of common stock (or common stock equivalents in lieu thereof) of the Company at a price to the public of $1.50 per share (or common stock equivalent), less underwriting discounts and commissions. The closing of the offering is expected

Astrotech Announces $10 Million Bought Deal Offering of Common Stock

The stock price of Astrotech Corp (NASDAQ: ASTC) increased by over 25% pre-market. This is why it happened.

Astrotech Stock Price Increased Over 25% Pre-Market: Why It Happened

AUSTIN, Texas--(BUSINESS WIRE)-- #Breathtech--Astrotech Corporation's (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed an Investigator-Initiated Study Agreement with the Cleveland Clinic Foundation (Cleveland Clinic). Under this agreement, BreathTech's BreathTest-1000™ will be used to compare exhaled breath from individuals who have tested positive on a COVID-19 polymerase chain reaction (PCR) test with that from subjects who have had a negative COVID-19 PCR test. The goal

Astrotech Subsidiary and Cleveland Clinic Sign Agreement for Breath Analysis Study to Develop a Rapid COVID-19 Breath Test

Sanmina-SCI

Astrotech Corporation (NASDAQ: ASTC) announced that its Astrotech Technologies subsidiary has entered into an agreement with Sanmina Corporation. These are the details  The post Astrotech (ASTC) Enters Agreement With Sanmina To Manufacture Mass Spectrometry Products appeared first on Pulse 2.0.

News for Astrotech Stock (ASTC)